Company Filing History:
1 out of 1 
1 out of 7 Years Active: 2017
Title: Gustavo Costa Bressan: Innovator in Vaccine Development
Introduction
Gustavo Costa Bressan is a notable inventor based in Viçosa, Brazil. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines against porcine circovirus 2 (PCV-2). His innovative work aims to improve animal health and combat diseases affecting swine.
Latest Patents
Bressan holds a patent for "Recombinant antigens of porcine circovirus 2 (PCV-2) for vaccine formulations, diagnostic kit and use thereof." This invention focuses on the preparation of recombinant antigens derived from the viral capsid of PCV-2. The process involves expression in a prokaryotic system, purification in monomer form, and recovery of virus-like particles (VLPs). These antigens are utilized in vaccine formulations and diagnostic kits, providing alternatives to existing commercial vaccines. Additionally, the ELISA kit developed can assess the quality of both commercial and experimental vaccines against PCV-2.
Career Highlights
Throughout his career, Bressan has worked with esteemed institutions such as the Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and the Universidade Federal de Viçosa. His research has focused on enhancing the immunization programs for swine, contributing to the overall health of livestock.
Collaborations
Bressan has collaborated with notable colleagues, including Márcia Rogéria de Almeida and Abelardo Silva Junior. These partnerships have fostered advancements in vaccine research and development.
Conclusion
Gustavo Costa Bressan's innovative work in vaccine development for porcine circovirus 2 represents a significant advancement in veterinary medicine. His contributions are vital for improving animal health and ensuring the effectiveness of immunization programs in swine breeding systems.